PolypStim
Uses existing endoscopes to bioelectrically read, diagnosis and deliver customized patient specific bioelectric signals to aide in shrinking polyps, fibroids and cysts and to promote rapid healing, reduced bleeding and rapid pain relief.
What is the PolypStim Technology Platform?
PolypStim uses standard endoscopes as a carrier to deliver bioelectric signals to polyps, cysts and fibroids to accelerate their shrinkage, prevent their reoccurrence, accelerate healing and also reduce bleeding, inflammation and pain.
Computer Generated Graphic For Representation Purposes Only
Not Actual Product
The global polyps market alone is expected to reach US$ 18.3 billion by 2023, and the market is projected to grow at a CAGR of ~ 9.2 % during the forecast period 2017-2023.
WANT TO LEARN MORE OR GET INVOLVED?
CAUTION Disclaimer and Warning: Products described on this web site are in early stage development and are not yet proven safe or effective in statistically significant controlled clinical studies. Any statement or phrases implying efficacy or safety in any form are considered modified by “intended to” or “designed to”. Investigational use only in countries where investigation is permitted by law and proper filings have been made and appropriate regulatory clearances have been granted. Any use of the product(s) must be in an authorized clinical study with institutional review board (ethics committee) approval and proper patient consent procedures followed. For other countries product is only available for laboratory investigation by credentialed institutions and investigators with proper clearances with a research agreement in place with a study sponsor. NOT AVAILABLE FOR SALE.